Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2025-12-24 @ 4:01 PM
NCT ID:
NCT05195866
Eligibility Criteria:
Inclusion Criteria:
* Between 6 month and 12 years of age;
* Parents/caregivers of a child are able and willing to comply with all study requirements;
* Parents/caregivers of a child is able and willing to give Informed Consent;
* Having at least one of the following focal symptoms lasting for less than 2 weeks (cough; fast/difficult breathing; dore throat; shortness of breath; wheezing)
Exclusion Criteria:
* Severely ill and in need of urgent referral where measurement of CRP POCT would delay the process;
* Terminally ill patients;
* Patients with ear ache only;
* Patients with known immunosuppression or severe chronic disease (HIV, liver disease, history of neoplastic disease, long term systemic steroid use or similar conditions as assessed by the health worker or AI);
* Parents/caregivers who are not able to participate in follow-up procedures (lack of telephone etc);
* Haven taken antibiotics within 24 hours before the index consultation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
12 Years
Study:
NCT05195866
Study Brief:
Protocol Section:
NCT05195866